Elevance Health Inc. (ELV) 10-Year Financial Performance & Capital Metrics

ELV • • Insurance & Managed Care

HealthcareHealth InsuranceNational Multi-Line Health Insurers

AboutElevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.Show more

Revenue $198.69B +12.4%
Combined Ratio 96.48% +1.0%
Net Income $5.66B -5.3%
Return on Equity 13.25% -10.4%
Medical Cost Ratio 43.84%
Operating Margin 3.52% -21.3%
Net Margin 2.85% -15.7%
ROA 4.75% -10.3%
Equity / Assets 36.24% +2.2%
Book Value per Share 198.49 +11.6%
Tangible BV/Share 20.21 +346.1%
Debt/Equity 0.73 -3.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓15 consecutive years of dividend growth
✓Low loss ratio of 43.8%
✓Healthy dividend yield of 2.2%
✓Share count reduced 4.8% through buybacks

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.64%

5Y10.27%

3Y8.26%

TTM12.37%

Profit (Net Income) CAGR

10Y8.26%

5Y4.37%

3Y-1.33%

TTM-5.32%

EPS CAGR

10Y10.35%

5Y6.92%

3Y1.14%

TTM-1.91%

ROCE

10Y Avg7.53%

5Y Avg7.9%

3Y Avg7.74%

Latest8.94%

Peer Comparison

National Multi-Line Health Insurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HUMHumana Inc.	22.92B	190.54	19.09	10.7%	1.02%	6.95%	10.43%	0.68
ELVElevance Health Inc.	70.63B	320.00	12.74	12.37%	2.85%	12.86%	4.49%	0.73

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue+	84.86B	90.04B	92.11B	104.21B	121.87B	138.64B	156.59B	171.34B	176.81B	198.69B
Revenue Growth %	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	12.37%
Medical Costs & Claims+	0	0	0	0	0	0	0	0	0	87.11B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	84.86B	90.04B	92.11B	104.21B	121.87B	138.64B	156.59B	171.34B	176.81B	111.58B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	-36.89%
Operating Expenses+	80.31B	86.08B	87.04B	98.23B	115.63B	130.64B	149B	163.63B	168.91B	104.59B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	912M	891M	1.13B	1.13B	1.15B	1.3B	1.68B	1.75B	1.39B	1.55B
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	4.55B	3.96B	5.07B	5.99B	6.24B	8B	7.6B	7.71B	7.9B	6.99B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.64%	-12.97%	27.85%	18.09%	4.23%	28.17%	-4.94%	1.51%	2.45%	-11.55%
EBITDA+	5.47B	4.86B	6.2B	7.12B	7.39B	9.3B	9.28B	9.46B	9.3B	8.54B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	723M	739M	753M	746M	784M	798M	851M	1.03B	1.19B	1.4B
Non-Operating Income	-723M	-739M	-753M	-746M	-784M	-798M	-851M	-1.03B	-1.19B	-1.12B
Pretax Income+	4.55B	3.96B	5.07B	5.99B	6.24B	8B	7.6B	7.71B	7.9B	6.71B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	2.08B	121M	1.32B	1.18B	1.67B	1.85B	1.71B	1.72B	1.93B	1.05B
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	2.47B	3.84B	3.75B	4.81B	4.57B	6.16B	5.89B	5.99B	5.98B	5.66B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-3.52%	55.59%	-2.42%	28.19%	-4.89%	34.69%	-4.29%	1.58%	-0.12%	-5.32%
EPS (Diluted)+	9.21	14.35	14.19	18.47	17.98	24.73	24.28	25.22	25.68	25.12
EPS Growth %	-1.81%	55.81%	-1.11%	30.16%	-2.65%	37.54%	-1.82%	3.87%	1.82%	-2.18%
EPS (Basic)	9.39	14.70	14.53	18.81	18.23	25.25	24.56	25.38	25.81	25.18
Diluted Shares Outstanding	268.1M	267.8M	254.3M	260.3M	254.3M	246.8M	242.8M	237.4M	232.9M	221.8M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets+	65.08B	70.54B	71.57B	77.45B	86.61B	97.46B	102.75B	108.93B	116.89B	121.49B
Asset Growth %	5.45%	8.38%	1.46%	8.22%	11.83%	12.52%	5.43%	6.01%	7.31%	3.94%
Total Investment Assets+	21.44B	24.93B	22.45B	25.45B	29.84B	34.01B	33.34B	36.83B	37.18B	0
Long-Term Investments	19.2B	21.59B	18.73B	21.19B	25.55B	28.78B	27.66B	30.72B	27.43B	0
Short-Term Investments	17.18B	17.39B	16.71B	19.68B	23.43B	26.27B	25.95B	29.61B	25.2B	0
Total Current Assets+	0	0	0	0	0	0	0	0	0	63B
Cash & Equivalents	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B	9.49B
Receivables	8.4B	8.79B	9.31B	10.39B	10.96B	13.44B	16.04B	17.86B	19.07B	0
Other Current Assets	-29.82B	-29.8B	-29.96B	-35B	-40.13B	-44.59B	-49.38B	-54.01B	-52.56B	53.51B
Goodwill & Intangibles+	25.53B	27.6B	29.51B	29.17B	31.1B	34.84B	34.7B	35.59B	40.37B	39.54B
Goodwill	17.56B	19.23B	20.5B	20.5B	21.69B	24.23B	24.38B	25.32B	28.28B	39.54B
Intangible Assets	7.96B	8.37B	9.01B	8.67B	9.4B	10.62B	10.31B	10.27B	12.09B	0
PP&E (Net)	1.98B	2.17B	2.73B	3.13B	3.48B	3.92B	4.32B	4.36B	4.65B	4.68B
Other Assets	-46.71B	-51.36B	-50.97B	-53.5B	-60.13B	-67.54B	-66.67B	-70.67B	-72.45B	14.27B
Total Liabilities	39.98B	44.04B	43.03B	45.73B	53.42B	61.33B	66.42B	69.52B	75.46B	77.47B
Total Debt+	15.73B	19.93B	19.21B	20.09B	20.04B	23.03B	24.11B	25.12B	31.23B	32.05B
Net Debt	11.65B	16.32B	15.28B	15.15B	14.29B	18.15B	16.73B	18.59B	22.94B	22.55B
Long-Term Debt	14.36B	17.38B	17.22B	17.79B	19.34B	21.16B	22.35B	23.25B	29.22B	30.8B
Short-Term Debt	1.37B	2.55B	1.99B	2.3B	700M	1.87B	1.76B	1.87B	2.01B	1.25B
Total Current Liabilities+	0	0	0	0	0	0	0	0	0	41.03B
Accounts Payable	11.91B	13.02B	12.41B	13.04B	16.85B	18.49B	21.2B	23.02B	22.67B	0
Deferred Revenue	971.9M	860M	902M	1.02B	1.26B	1.15B	1.11B	1.4B	1.51B	0
Other Current Liabilities	-15.42B	-16.99B	-16.11B	-16.36B	-18.81B	-21.52B	-24.08B	-26.3B	-26.2B	39.79B
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Other Liabilities	-17.14B	-19.11B	-19.18B	-20.01B	-21.35B	-23.96B	-24.36B	-25.22B	-31.37B	-30.8B
Total Equity+	25.1B	26.5B	28.54B	31.73B	33.2B	36.13B	36.33B	39.41B	41.43B	44.03B
Equity Growth %	8.92%	5.59%	7.69%	11.17%	4.64%	8.82%	0.56%	8.46%	5.13%	6.28%
Shareholders Equity	25.1B	26.5B	28.54B	31.73B	33.2B	36.06B	36.24B	39.31B	41.31B	43.88B
Minority Interest	0	0	0	0	0	68M	87M	99M	111M	144M
Retained Earnings	16.56B	18.05B	19.99B	22.57B	23.8B	27.09B	29.65B	31.75B	33.55B	0
Common Stock	2.6M	3M	3M	3M	3M	2M	2M	2M	2M	0
Accumulated OCI	-267.9M	-101M	-986M	-296M	150M	-178M	-2.49B	-1.31B	-1.15B	0
Return on Equity (ROE)	10.26%	14.89%	13.63%	15.95%	14.08%	17.77%	16.27%	15.81%	14.8%	13.25%
Return on Assets (ROA)	3.9%	5.67%	5.28%	6.45%	5.57%	6.69%	5.89%	5.66%	5.3%	4.75%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.63x	0.75x	0.67x	0.63x	0.60x	0.64x	0.66x	0.64x	0.75x	0.73x
Book Value per Share	93.62	98.97	112.23	121.89	130.55	146.39	149.63	165.99	177.87	198.49
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	3.2B	4.18B	3.83B	6.06B	10.69B	8.36B	8.4B	8.06B	5.81B	4.29B
Operating CF Growth %	-22.15%	30.59%	-8.55%	58.37%	76.34%	-21.74%	0.42%	-4.02%	-27.95%	-26.14%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	2.47B	3.84B	3.75B	4.81B	4.57B	6.09B	6.02B	5.99B	5.97B	5.66B
Depreciation & Amortization	911.8M	890.4M	1.13B	1.13B	1.15B	1.3B	1.68B	1.75B	1.39B	1.55B
Stock-Based Compensation	164.6M	169.6M	226M	294M	283M	255M	264M	289M	191M	276M
Deferred Taxes	126.9M	-1.27B	91M	81M	-540M	173M	-76M	-602M	-374M	0
Other Non-Cash Items	106.3M	186.2M	235M	-62M	16M	-245M	264M	1.18B	346M	487M
Working Capital Changes	-574.9M	367.9M	-1.6B	-192M	5.2B	784M	253M	-535M	-1.72B	-3.68B
Cash from Investing+	-513.9M	-5.08B	-1.26B	-2.79B	-7.32B	-9.64B	-4.56B	-5.57B	-5.17B	-1.34B
Capital Expenditures	-583.6M	-790.2M	-1.21B	-1.08B	-1.02B	-1.09B	-1.15B	-1.3B	-1.26B	-1.12B
Acquisitions	0	-2.08B	-1.76B	0	-1.98B	-3.48B	-649M	-1.55B	-4.45B	0
Purchase of Investments	-12.1B	-16.37B	-9.67B	-22.95B	-19.49B	-18.67B	-24.95B	-16.24B	-17.99B	0
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	219M	636.4M	-220M	204M	-894M	-1.02B	-421M	-24M	-51M	-297M
Cash from Financing+	-732.9M	426.9M	-2.24B	-2.27B	-2.57B	423M	-1.32B	-3.35B	1.19B	-1.74B
Dividends Paid	-684M	-704.9M	-776M	-818M	-954M	-1.1B	-1.23B	-1.4B	-1.51B	-1.53B
Share Repurchases	-67M	-2B	-1.69B	-1.7B	-2.7B	-1.9B	-2.32B	-2.68B	-2.9B	-2.6B
Stock Issued	0	0	1.25B	0	0	0	0	0	0	0
Debt Issuance (Net)	1000K	1000K	-1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Financing	-408.9M	-820.7M	-355M	-271M	899M	1.08B	432M	-17M	39M	1.77B
Net Change in Cash+	1.96B	-466.4M	325M	1B	804M	-861M	2.51B	-861M	1.76B	1.2B
Exchange Rate Effect	1000K	1000K	-1000K	0	1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Cash at Beginning	2.11B	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B
Cash at End	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B	9.49B
Free Cash Flow+	2.62B	3.39B	2.62B	4.98B	9.67B	7.28B	7.25B	6.76B	4.55B	3.17B
FCF Growth %	-25.4%	29.52%	-22.85%	90.3%	93.96%	-24.72%	-0.41%	-6.65%	-32.71%	-30.27%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	9.78	12.68	10.3	19.15	38.01	29.49	29.85	28.5	19.54	14.31

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Combined Ratio	94.63%	95.6%	94.5%	94.26%	94.88%	94.23%	95.15%	95.5%	95.53%	96.48%
Medical Cost Ratio	0%	0%	0%	0%	0%	0%	0%	0%	0%	43.84%
Return on Equity (ROE)	10.26%	14.89%	13.63%	15.95%	14.08%	17.77%	16.27%	15.81%	14.8%	13.25%
Return on Assets (ROA)	3.9%	5.67%	5.28%	6.45%	5.57%	6.69%	5.89%	5.66%	5.3%	4.75%
Equity / Assets	38.57%	37.57%	39.88%	40.96%	38.33%	37.07%	35.36%	36.18%	35.44%	36.24%
Book Value / Share	93.62	98.97	112.23	121.89	130.55	146.39	149.63	165.99	177.87	198.49
Debt / Equity	0.63x	0.75x	0.67x	0.63x	0.60x	0.64x	0.66x	0.64x	0.75x	0.73x
Revenue Growth	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	12.37%

US Stock Screener

...

Elevance Health Inc. (ELV) 10-Year Financial Performance & Capital Metrics

ELV • • Insurance & Managed Care

HealthcareHealth InsuranceNational Multi-Line Health Insurers

Revenue $198.69B +12.4%
Combined Ratio 96.48% +1.0%
Net Income $5.66B -5.3%
Return on Equity 13.25% -10.4%
Medical Cost Ratio 43.84%
Operating Margin 3.52% -21.3%
Net Margin 2.85% -15.7%
ROA 4.75% -10.3%
Equity / Assets 36.24% +2.2%
Book Value per Share 198.49 +11.6%
Tangible BV/Share 20.21 +346.1%
Debt/Equity 0.73 -3.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓15 consecutive years of dividend growth
✓Low loss ratio of 43.8%
✓Healthy dividend yield of 2.2%
✓Share count reduced 4.8% through buybacks

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.64%

5Y10.27%

3Y8.26%

TTM12.37%

Profit (Net Income) CAGR

10Y8.26%

5Y4.37%

3Y-1.33%

TTM-5.32%

EPS CAGR

10Y10.35%

5Y6.92%

3Y1.14%

TTM-1.91%

ROCE

10Y Avg7.53%

5Y Avg7.9%

3Y Avg7.74%

Latest8.94%

Peer Comparison

National Multi-Line Health Insurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HUMHumana Inc.	22.92B	190.54	19.09	10.7%	1.02%	6.95%	10.43%	0.68
ELVElevance Health Inc.	70.63B	320.00	12.74	12.37%	2.85%	12.86%	4.49%	0.73

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue+	84.86B	90.04B	92.11B	104.21B	121.87B	138.64B	156.59B	171.34B	176.81B	198.69B
Revenue Growth %	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	12.37%
Medical Costs & Claims+	0	0	0	0	0	0	0	0	0	87.11B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	84.86B	90.04B	92.11B	104.21B	121.87B	138.64B	156.59B	171.34B	176.81B	111.58B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	-36.89%
Operating Expenses+	80.31B	86.08B	87.04B	98.23B	115.63B	130.64B	149B	163.63B	168.91B	104.59B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	912M	891M	1.13B	1.13B	1.15B	1.3B	1.68B	1.75B	1.39B	1.55B
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	4.55B	3.96B	5.07B	5.99B	6.24B	8B	7.6B	7.71B	7.9B	6.99B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.64%	-12.97%	27.85%	18.09%	4.23%	28.17%	-4.94%	1.51%	2.45%	-11.55%
EBITDA+	5.47B	4.86B	6.2B	7.12B	7.39B	9.3B	9.28B	9.46B	9.3B	8.54B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	723M	739M	753M	746M	784M	798M	851M	1.03B	1.19B	1.4B
Non-Operating Income	-723M	-739M	-753M	-746M	-784M	-798M	-851M	-1.03B	-1.19B	-1.12B
Pretax Income+	4.55B	3.96B	5.07B	5.99B	6.24B	8B	7.6B	7.71B	7.9B	6.71B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	2.08B	121M	1.32B	1.18B	1.67B	1.85B	1.71B	1.72B	1.93B	1.05B
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	2.47B	3.84B	3.75B	4.81B	4.57B	6.16B	5.89B	5.99B	5.98B	5.66B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-3.52%	55.59%	-2.42%	28.19%	-4.89%	34.69%	-4.29%	1.58%	-0.12%	-5.32%
EPS (Diluted)+	9.21	14.35	14.19	18.47	17.98	24.73	24.28	25.22	25.68	25.12
EPS Growth %	-1.81%	55.81%	-1.11%	30.16%	-2.65%	37.54%	-1.82%	3.87%	1.82%	-2.18%
EPS (Basic)	9.39	14.70	14.53	18.81	18.23	25.25	24.56	25.38	25.81	25.18
Diluted Shares Outstanding	268.1M	267.8M	254.3M	260.3M	254.3M	246.8M	242.8M	237.4M	232.9M	221.8M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets+	65.08B	70.54B	71.57B	77.45B	86.61B	97.46B	102.75B	108.93B	116.89B	121.49B
Asset Growth %	5.45%	8.38%	1.46%	8.22%	11.83%	12.52%	5.43%	6.01%	7.31%	3.94%
Total Investment Assets+	21.44B	24.93B	22.45B	25.45B	29.84B	34.01B	33.34B	36.83B	37.18B	0
Long-Term Investments	19.2B	21.59B	18.73B	21.19B	25.55B	28.78B	27.66B	30.72B	27.43B	0
Short-Term Investments	17.18B	17.39B	16.71B	19.68B	23.43B	26.27B	25.95B	29.61B	25.2B	0
Total Current Assets+	0	0	0	0	0	0	0	0	0	63B
Cash & Equivalents	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B	9.49B
Receivables	8.4B	8.79B	9.31B	10.39B	10.96B	13.44B	16.04B	17.86B	19.07B	0
Other Current Assets	-29.82B	-29.8B	-29.96B	-35B	-40.13B	-44.59B	-49.38B	-54.01B	-52.56B	53.51B
Goodwill & Intangibles+	25.53B	27.6B	29.51B	29.17B	31.1B	34.84B	34.7B	35.59B	40.37B	39.54B
Goodwill	17.56B	19.23B	20.5B	20.5B	21.69B	24.23B	24.38B	25.32B	28.28B	39.54B
Intangible Assets	7.96B	8.37B	9.01B	8.67B	9.4B	10.62B	10.31B	10.27B	12.09B	0
PP&E (Net)	1.98B	2.17B	2.73B	3.13B	3.48B	3.92B	4.32B	4.36B	4.65B	4.68B
Other Assets	-46.71B	-51.36B	-50.97B	-53.5B	-60.13B	-67.54B	-66.67B	-70.67B	-72.45B	14.27B
Total Liabilities	39.98B	44.04B	43.03B	45.73B	53.42B	61.33B	66.42B	69.52B	75.46B	77.47B
Total Debt+	15.73B	19.93B	19.21B	20.09B	20.04B	23.03B	24.11B	25.12B	31.23B	32.05B
Net Debt	11.65B	16.32B	15.28B	15.15B	14.29B	18.15B	16.73B	18.59B	22.94B	22.55B
Long-Term Debt	14.36B	17.38B	17.22B	17.79B	19.34B	21.16B	22.35B	23.25B	29.22B	30.8B
Short-Term Debt	1.37B	2.55B	1.99B	2.3B	700M	1.87B	1.76B	1.87B	2.01B	1.25B
Total Current Liabilities+	0	0	0	0	0	0	0	0	0	41.03B
Accounts Payable	11.91B	13.02B	12.41B	13.04B	16.85B	18.49B	21.2B	23.02B	22.67B	0
Deferred Revenue	971.9M	860M	902M	1.02B	1.26B	1.15B	1.11B	1.4B	1.51B	0
Other Current Liabilities	-15.42B	-16.99B	-16.11B	-16.36B	-18.81B	-21.52B	-24.08B	-26.3B	-26.2B	39.79B
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Other Liabilities	-17.14B	-19.11B	-19.18B	-20.01B	-21.35B	-23.96B	-24.36B	-25.22B	-31.37B	-30.8B
Total Equity+	25.1B	26.5B	28.54B	31.73B	33.2B	36.13B	36.33B	39.41B	41.43B	44.03B
Equity Growth %	8.92%	5.59%	7.69%	11.17%	4.64%	8.82%	0.56%	8.46%	5.13%	6.28%
Shareholders Equity	25.1B	26.5B	28.54B	31.73B	33.2B	36.06B	36.24B	39.31B	41.31B	43.88B
Minority Interest	0	0	0	0	0	68M	87M	99M	111M	144M
Retained Earnings	16.56B	18.05B	19.99B	22.57B	23.8B	27.09B	29.65B	31.75B	33.55B	0
Common Stock	2.6M	3M	3M	3M	3M	2M	2M	2M	2M	0
Accumulated OCI	-267.9M	-101M	-986M	-296M	150M	-178M	-2.49B	-1.31B	-1.15B	0
Return on Equity (ROE)	10.26%	14.89%	13.63%	15.95%	14.08%	17.77%	16.27%	15.81%	14.8%	13.25%
Return on Assets (ROA)	3.9%	5.67%	5.28%	6.45%	5.57%	6.69%	5.89%	5.66%	5.3%	4.75%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.63x	0.75x	0.67x	0.63x	0.60x	0.64x	0.66x	0.64x	0.75x	0.73x
Book Value per Share	93.62	98.97	112.23	121.89	130.55	146.39	149.63	165.99	177.87	198.49
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	3.2B	4.18B	3.83B	6.06B	10.69B	8.36B	8.4B	8.06B	5.81B	4.29B
Operating CF Growth %	-22.15%	30.59%	-8.55%	58.37%	76.34%	-21.74%	0.42%	-4.02%	-27.95%	-26.14%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	2.47B	3.84B	3.75B	4.81B	4.57B	6.09B	6.02B	5.99B	5.97B	5.66B
Depreciation & Amortization	911.8M	890.4M	1.13B	1.13B	1.15B	1.3B	1.68B	1.75B	1.39B	1.55B
Stock-Based Compensation	164.6M	169.6M	226M	294M	283M	255M	264M	289M	191M	276M
Deferred Taxes	126.9M	-1.27B	91M	81M	-540M	173M	-76M	-602M	-374M	0
Other Non-Cash Items	106.3M	186.2M	235M	-62M	16M	-245M	264M	1.18B	346M	487M
Working Capital Changes	-574.9M	367.9M	-1.6B	-192M	5.2B	784M	253M	-535M	-1.72B	-3.68B
Cash from Investing+	-513.9M	-5.08B	-1.26B	-2.79B	-7.32B	-9.64B	-4.56B	-5.57B	-5.17B	-1.34B
Capital Expenditures	-583.6M	-790.2M	-1.21B	-1.08B	-1.02B	-1.09B	-1.15B	-1.3B	-1.26B	-1.12B
Acquisitions	0	-2.08B	-1.76B	0	-1.98B	-3.48B	-649M	-1.55B	-4.45B	0
Purchase of Investments	-12.1B	-16.37B	-9.67B	-22.95B	-19.49B	-18.67B	-24.95B	-16.24B	-17.99B	0
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	219M	636.4M	-220M	204M	-894M	-1.02B	-421M	-24M	-51M	-297M
Cash from Financing+	-732.9M	426.9M	-2.24B	-2.27B	-2.57B	423M	-1.32B	-3.35B	1.19B	-1.74B
Dividends Paid	-684M	-704.9M	-776M	-818M	-954M	-1.1B	-1.23B	-1.4B	-1.51B	-1.53B
Share Repurchases	-67M	-2B	-1.69B	-1.7B	-2.7B	-1.9B	-2.32B	-2.68B	-2.9B	-2.6B
Stock Issued	0	0	1.25B	0	0	0	0	0	0	0
Debt Issuance (Net)	1000K	1000K	-1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Financing	-408.9M	-820.7M	-355M	-271M	899M	1.08B	432M	-17M	39M	1.77B
Net Change in Cash+	1.96B	-466.4M	325M	1B	804M	-861M	2.51B	-861M	1.76B	1.2B
Exchange Rate Effect	1000K	1000K	-1000K	0	1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Cash at Beginning	2.11B	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B
Cash at End	4.08B	3.61B	3.93B	4.94B	5.74B	4.88B	7.39B	6.53B	8.29B	9.49B
Free Cash Flow+	2.62B	3.39B	2.62B	4.98B	9.67B	7.28B	7.25B	6.76B	4.55B	3.17B
FCF Growth %	-25.4%	29.52%	-22.85%	90.3%	93.96%	-24.72%	-0.41%	-6.65%	-32.71%	-30.27%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	9.78	12.68	10.3	19.15	38.01	29.49	29.85	28.5	19.54	14.31

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Combined Ratio	94.63%	95.6%	94.5%	94.26%	94.88%	94.23%	95.15%	95.5%	95.53%	96.48%
Medical Cost Ratio	0%	0%	0%	0%	0%	0%	0%	0%	0%	43.84%
Return on Equity (ROE)	10.26%	14.89%	13.63%	15.95%	14.08%	17.77%	16.27%	15.81%	14.8%	13.25%
Return on Assets (ROA)	3.9%	5.67%	5.28%	6.45%	5.57%	6.69%	5.89%	5.66%	5.3%	4.75%
Equity / Assets	38.57%	37.57%	39.88%	40.96%	38.33%	37.07%	35.36%	36.18%	35.44%	36.24%
Book Value / Share	93.62	98.97	112.23	121.89	130.55	146.39	149.63	165.99	177.87	198.49
Debt / Equity	0.63x	0.75x	0.67x	0.63x	0.60x	0.64x	0.66x	0.64x	0.75x	0.73x
Revenue Growth	7.21%	6.1%	2.29%	13.15%	16.94%	13.76%	12.95%	9.42%	3.19%	12.37%

Elevance Health Inc. (ELV) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ELV vs Peers

vs HUM

vs AGIO

Compare Top 3

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Elevance Health Inc. (ELV) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ELV vs Peers

vs HUM

vs AGIO

Compare Top 3

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios